tasimelteon FDA approval date

The FDA approved tasimelteon (VEC-162) on 31 Jan 2014.

FDA approval date
31 Jan 2014

Drug identity checked against registry records

Also recorded as VEC-162

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2014-01-31DaytasimelteonFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205677", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140131", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026